BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20644120)

  • 1. How I treat elderly patients with myeloma.
    Mehta J; Cavo M; Singhal S
    Blood; 2010 Sep; 116(13):2215-23. PubMed ID: 20644120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management update: multiple myeloma.
    Stoopler ET; Vogl DT; Stadtmauer EA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):599-609. PubMed ID: 17291793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of multiple myeloma.
    UK myeloma forum. British Committee for Standards in Haematology
    Br J Haematol; 2001 Dec; 115(3):522-40. PubMed ID: 11736932
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing multiple myeloma in the over 70s: a review.
    King AJ; Gooding S; Ramasamy K
    Maturitas; 2015 Feb; 80(2):148-54. PubMed ID: 25541475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
    Tariman JD; Estrella SM
    Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part I: the role of maintenance therapy in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
    McCarthy PL
    J Natl Compr Canc Netw; 2013 Jan; 11(1):35-42. PubMed ID: 23307979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma: diagnosis complications and supportive care.
    Morgan G
    Hematology; 2012 Apr; 17 Suppl 1():S109-11. PubMed ID: 22507795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Integrated supportive therapy for multiple myeloma-bone disease treatment, myeloma kidney treatment, cryotherapy, nutrition support team].
    Miwa A
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():603-27. PubMed ID: 23134022
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and emerging treatments for multiple myeloma.
    Schwartz RN; Vozniak M
    J Manag Care Pharm; 2008 Sep; 14(7 Suppl):12-9. PubMed ID: 18774881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
    Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1115-21. PubMed ID: 20197100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of myeloma.
    Smith ML; Newland AC
    QJM; 1999 Jan; 92(1):11-4. PubMed ID: 10209667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
    Pérez R; Durán MS; Mayans J; Soler A; Castillo I; Jurado M; Ribas P; Menchaca Echevarria MC; Hernandez MT; Lopez Garcia-Carreño MD; Echeveste Gutierrez A; Bailen Garcia A; Lopez S; Baquero J; Ramirez G
    Eur J Haematol; 2016 Apr; 96(4):417-24. PubMed ID: 26190662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment for multiple myeloma: current status and future strategy in Japan].
    Iida S
    Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple myeloma. Diagnosis and therapy].
    Goldschmidt H; Cremer FW; Möhler TM; Ho AD
    Internist (Berl); 2003 May; 44(5):599-600, 603-16; quiz 617-8. PubMed ID: 12966788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment options for myeloma.
    Terpos E; Rahemtulla A; Dimopoulos MA
    Expert Opin Pharmacother; 2005 Jun; 6(7):1127-42. PubMed ID: 15957967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of autologous hematopoietic stem cell transplantation in multiple myeloma.
    Harousseau JL; Attal M
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):61-6. PubMed ID: 9122747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
    Nooka AK; Harvey RD; Langston A; Collins H; Lonial S; Kaufman JL
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e59-63. PubMed ID: 24378319
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical treatment of newly diagnosed multiple myeloma.
    Cejalvo MJ; de la Rubia J
    Expert Rev Hematol; 2015 Oct; 8(5):595-611. PubMed ID: 26327587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.